journal article·2023

Virus-like silica nanoparticles enhance macromolecule permeation in vivo

Yuxue Cao, Taskeen Iqbal Janjua, Zhi Qu, Bastian Draphoen, Yunfan Bai, Mika Linden, Md Moniruzzaman, Sumaira Z. Hasnain, Tushar Kumeria, Amirali Popat

Biomaterials Science· Volume 11· Issue 13
Publisher page

Abstract

Nanoparticle based permeation enhancers have the potential to improve the oral delivery of biologics. Recently, solid silica nanoparticles were discovered to improve the intestinal permeability of peptides and proteins via transient opening of the gut epithelium. In this study, we have developed small-sized (∼60 nm) virus-like silica nanoparticles (VSNP) as a reversible and next generation non-toxic permeation enhancer for oral delivery of biologics. Our results show that the anionic VSNP showed a better permeation-enhancing effect than the same sized spherical Stöber silica nanoparticles (∼60 nm) by enhancing the apparent insulin permeability by 1.3-fold in the Caco-2 monolayer model and by 1.2-fold in the Caco-2/MTX-HT-29 co-culture model. In vivo experiments in healthy mice demonstrated that anionic VSNP significantly enhanced the permeation of fluorescently labelled 4 kDa dextran after oral administration compared to Stöber nanoparticles and positively charged VSNP. The results indicated that the nanoscale surface roughness is an important consideration when designing nanoparticle-based permeation enhancers. Overall, our study shows for the first time that small-sized (∼60 nm) VSNP with nanoscale surface roughness can be used as a non-toxic permeation enhancer for oral delivery of therapeutic peptides and proteins.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, The University of Queensland, Brisbane, QLD, 4102, Australia

Institute of Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany

Faculty of Medicine, The University of Queensland, 37 Kent Street, Woolloongabba, QLD 4102, Australia

Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Translational Research Institute (TRI), Woolloongabba, QLD, 4102, Australia

Immunopathology Group, Mater Research Institute, The University of Queensland, Translational Research Institute, Brisbane, QLD, 4102, Australia

Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, 4102, Australia

School of Materials Science and Engineering, The University of New South Wales, Sydney, NSW, 2052, Australia

Australian Centre for Nanomedicine, The University of New South Wales, Sydney, NSW, 2052, Australia

Funding

University of Queensland · National Health and Medical Research Council

References (58)

Show source-provided references
1. Brown · J. Med. Chem. · 2021 · 64 · 231210.1021/acs.jmedchem.0c01516 ↗
2. Cao · Trends Pharmacol. Sci. · 2021 · 42 · 95710.1016/j.tips.2021.08.005 ↗
3. Ibeanu · Pharmaceutics · 2020 · 12 · 99910.3390/pharmaceutics12100999 ↗
4. Ji · Adv. Ther. · 2019 · 36 · 148510.1007/s12325-019-00951-4 ↗
5. Tremolada · Behav. Sci. · 2021 · 11 · 9810.3390/bs11070098 ↗
6. Yang · Angew. Chem., Int. Ed. · 2023 · 62 · e20221479510.1002/anie.202214795 ↗
7. Yun · Adv. Drug Delivery Rev. · 2013 · 65 · 82210.1016/j.addr.2012.10.007 ↗
8. Liu · Expert Opin. Drug Delivery · 2018 · 15 · 22310.1080/17425247.2017.1395853 ↗
9. Hassan · Expert Opin. Drug Delivery · 2010 · 7 · 9710.1517/17425240903338758 ↗
10. Xu · Front. Chem. · 2019 · 7 · 29010.3389/fchem.2019.00290 ↗
11. Yang · Acc. Chem. Res. · 2020 · 53 · 154510.1021/acs.accounts.0c00280 ↗
12. Peng · Front. Bioeng. Biotechnol. · 2021 · 74938110.3389/fbioe.2021.749381 ↗
13. Arap · Curr. Med. Chem. · 2013 · 20 · 219510.2174/0929867311320170005 ↗
14. Selvarajan · Front. Chem. · 2020 · 60210.3389/fchem.2020.00602 ↗
15. Ndayishimiye · J. Mater. Chem. B · 2021 · 9 · 714510.1039/D1TB01430G ↗
16. Tasia · Nanoscale · 2020 · 12 · 232810.1039/C9NR08467C ↗
17. Janjua · Nat. Rev. Mater. · 2021 · 6 · 107210.1038/s41578-021-00385-x ↗
18. Tan · Drug Delivery Transl. Res. · 2014 · 4 · 21210.1007/s13346-013-0172-9 ↗
19. Bukara · Eur. J. Pharm. Biopharm. · 2016 · 108 · 22010.1016/j.ejpb.2016.08.020 ↗
20. Zanoni · JAMA Network Open · 2021 · 4 · e21193610.1001/jamanetworkopen.2021.1936 ↗
21. Phillips · Sci. Transl. Med. · 2014 · 6 · 260ra14910.1126/scitranslmed.3009524 ↗
22. Kharlamov · Nanoscale · 2015 · 7 · 800310.1039/C5NR01050K ↗
23. Rastinehad · Proc. Natl. Acad. Sci. U. S. A. · 2019 · 116 · 1859010.1073/pnas.1906929116 ↗
24. Abeer · J. Controlled Release · 2020 · 326 · 54410.1016/j.jconrel.2020.07.021 ↗
25. Diab · Adv. Colloid Interface Sci. · 2017 · 249 · 34610.1016/j.cis.2017.04.005 ↗
26. Fruijtier-Pölloth · Arch. Toxicol. · 2016 · 90 · 288510.1007/s00204-016-1850-4 ↗
27. Niu · J. Mater. Chem. B · 2016 · 4 · 21210.1039/C5TB01911G ↗
28. Niu · J. Mater. Chem. B · 2015 · 3 · 847710.1039/C5TB01405K ↗
29. Xu · Nano Res. · 2020 · 13 · 232310.1007/s12274-020-2783-z ↗
30. Wang · ACS Cent. Sci. · 2017 · 3 · 83910.1021/acscentsci.7b00257 ↗
31. Haffner · ACS Nano · 2021 · 15 · 678710.1021/acsnano.0c10378 ↗
32. Lamson · Nat. Biomed. Eng. · 2020 · 4 · 8410.1038/s41551-019-0465-5 ↗
33. Zhang · ACS Appl. Mater. Interfaces · 2021 · 13 · 1807710.1021/acsami.1c00580 ↗
34. Yu · Nano Res. · 2016 · 9 · 29110.1007/s12274-015-0909-5 ↗
35. Janjua · Nanoscale · 2021 · 13 · 1690910.1039/D1NR03553C ↗
36. Janjua · J. Controlled Release · 2023 · 357 · 16110.1016/j.jconrel.2023.03.040 ↗
37. Lamson · Pharm. Res. · 2019 · 36 · 110.1007/s11095-019-2712-6 ↗
38. Kämpfer · In Vitro Models · 2022 · 1
39. Yamaura · Drug Metab. Dispos. · 2016 · 44 · 32910.1124/dmd.115.068429 ↗
40. Gautam · Mater. Today: Proc. · 2023 · 74 · 713
41. T.Lea , The impact of food bioactives on health , 2015 , pp. 103–111
42. Lesuffleur · Cancer Res. · 1990 · 50 · 6334
43. Gagnon · J. Microbiol. Methods · 2013 · 94 · 27410.1016/j.mimet.2013.06.027 ↗
44. Niu · Adv. Mater. · 2013 · 25 · 623310.1002/adma.201302737 ↗
45. Frietze · Curr. Opin. Virol. · 2016 · 18 · 4410.1016/j.coviro.2016.03.001 ↗
46. Liu · ACS Nano · 2023 · 17 · 689910.1021/acsnano.3c00644 ↗
47. Kuo · Ann. N. Y. Acad. Sci. · 2022 · 1514 · 2110.1111/nyas.14798 ↗
48. Turner · Nat. Rev. Immunol. · 2009 · 9 · 79910.1038/nri2653 ↗
49. Lu · Tissue Barriers · 2013 · 1 · e2497810.4161/tisb.24978 ↗
50. Hidalgo · Gastroenterology · 1989 · 96 · 73610.1016/S0016-5085(89)80072-1 ↗
51. Boulenc · Biochem. Pharmacol. · 1993 · 46 · 159110.1016/0006-2952(93)90328-T ↗
52. Walter · J. Pharm. Sci. · 1996 · 85 · 107010.1021/js960110x ↗
53. Béduneau · Eur. J. Pharm. Biopharm. · 2014 · 87 · 29010.1016/j.ejpb.2014.03.017 ↗
54. Costa · Mater. Sci. Eng., C · 2021 · 119 · 11155110.1016/j.msec.2020.111551 ↗
55. Srinivasan · J. Lab. Autom. · 2015 · 20 · 10710.1177/2211068214561025 ↗
56. Qu · Adv. Ther. · 2021 · 4 · 200016510.1002/adtp.202000165 ↗
57. Finbloom · Nat. Rev. Bioeng. · 2023 · 1
58. Anselmo · ACS Nano · 2014 · 8 · 1124310.1021/nn503732m ↗